Mark A. Goldsmith
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update Wikipedia
Mark A. Goldsmith, M.D., Ph.D., is a biotechnology executive at Revolution Medicines. He currently serves as President, Chief Executive Officer, and Chairman of the Board at the company. Revolution Medicines identifies him on its leadership and team pages, and the supplied evidence supports this identity rather than the same-named federal judge listed on Wikipedia.
Updated 9 October 2026
Public sources: revmed.com revmed.com revmed.com Wikipedia
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Mark A. Goldsmith appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data